Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier - Wikidata - awgldk - TriplyDB

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

http://www.wikidata.org/entity/Q33928434

about

Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?The Possible Role of Antioxidant Vitamin C in Alzheimer's Disease Treatment and Prevention SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy Clearance of amyloid-beta by circulating lipoprotein receptors MyD88 deficiency ameliorates β-amyloidosis in an animal model of Alzheimer's disease In normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with limited distribution into brain.Novel Abeta peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease.Intracerebral haemorrhage in Down syndrome: protected or predisposed?Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease Endocrine Risk Factors for Cognitive Impairment Hypertension and Dementia: Epidemiological and Experimental Evidence Revealing a Detrimental Relationship Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases Amyloid-β Receptors: The Good, the Bad, and the Prion Protein Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1 Clearance systems in the brain-implications for Alzheimer disease Cell-culture models of the blood-brain barrier The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease The pericyte: a forgotten cell type with important implications for Alzheimer's disease?Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease Intravenous immunoglobulin and Alzheimer's disease: what now?Interaction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanisms The pathobiology of vascular dementia Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier Presumed LRP1-targeting transport peptide delivers β-secretase inhibitor to neurons in vitro with limited efficiency A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model Amyloid-β peptide-specific DARPins as a novel class of potential therapeutics for Alzheimer disease The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.Neuronal clearance of amyloid-β by endocytic receptor LRP1.LRP: a multifunctional scavenger and signaling receptor

P2860

Q21129438-8335A1B5-30C5-4896-972B-31BC26BBED63 Q21202832-37D0B045-EEA1-4ED7-98F3-A1AE4461A735 Q22241784-A2A58F05-ED33-4AFD-832F-B5DEFADFD896 Q24309440-93A7C714-FAF3-46F0-99ED-BC93B46D1FE0 Q24604376-C95AFC97-C861-4A7E-B296-FC72DACBA122 Q24613781-880C9026-E558-40B8-9B1E-B2E7315A5ADF Q24616286-28CF557D-64DF-4421-A488-81BE9028354A Q24815635-D073BCBF-A1C8-4EB4-9D04-BA243AB54DAF Q25256570-349D9802-7A08-469B-A422-3E7C481C0590 Q26745369-8E465DDC-3E90-44EB-B818-C1E2E0D98A3E Q26747527-312E22F8-1E59-4DDE-91E2-13CBA52A7BB0 Q26749493-D86C5D94-8278-4D01-85C1-19AEFA39262C Q26752595-F64172CA-123F-4B0A-935F-8C9E3C3DC4E1 Q26753215-69265E2E-A910-486D-9FF9-3281AB7B1C09 Q26771532-58204F42-950A-41A1-B07D-B721CE82136B Q26776375-4CA029E2-0F7A-4B46-A0E4-108889373EAA Q26800063-143D48BD-169C-4F46-BBFE-002BCBF84F58 Q26801541-5947D411-50C9-464D-A0C1-F2E2CBD59DE3 Q26827093-F30CB260-3770-405D-B5A4-AF8D5363AE56 Q26827353-0B59786C-892F-4F64-896C-EF9BD3E96222 Q26852369-B3A1FEF6-56A7-4D5C-BCD1-E3B16CD2B002 Q26858870-6A295D81-4948-4A26-889D-CA6891C89C82 Q27000371-2651C933-89EB-41E4-A58D-56E66122F559 Q27001177-CDFBB09A-9BAA-4EC4-A1B4-FCE83364DDBA Q27006033-8FC850CE-7852-4475-9CE5-57CF3137D688 Q27022365-9318200D-C11F-4BAB-8949-583424E16FBA Q27332086-118E9576-0407-4ABA-82B7-F6A8DA0B7DE1 Q27341864-6AD2F837-ADDF-4EBB-98E5-66A4BD94BE25 Q28261647-2CEF118D-D3AE-4B9F-88B5-796007062215 Q28285617-671A70EF-624E-4BA3-B718-052FE4593A6F Q28586383-155DBEFD-CE42-4D57-A6C2-CC6F51882047 Q28588684-65F60C0F-462B-48F4-9F69-A03BA060A01F Q28654400-709FEDBC-C87C-4B90-894F-09C4A0DEC6C6 Q28655482-2F3DC447-C6CC-4B74-9659-965E2FDA643B Q28742884-E5543AB7-E48E-4026-A70C-F17C3657D442 Q28910485-286F752C-EAEF-4195-ADB3-B69F9B0C8179 Q29615839-E05DEC1D-BD72-483C-8C3D-317F458060CC Q29976920-FD5ABC00-FD4E-4B73-8CDC-72D2F497E16A Q29977780-73382240-D7A5-413B-B278-6419C0356844 Q30004206-CFAB535B-B913-4145-8926-1BB6664577B8

P2860

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

http://www.wikidata.org/entity/Q33928434

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Clearance of Alzheimer's amylo ...... n-1 at the blood-brain barrier

@ast

Clearance of Alzheimer's amylo ...... n-1 at the blood-brain barrier

@en

type

label

Clearance of Alzheimer's amylo ...... n-1 at the blood-brain barrier

@ast

Clearance of Alzheimer's amylo ...... n-1 at the blood-brain barrier

@en

altLabel

Clearance of Alzheimer’s amylo ...... n-1 at the blood-brain barrier

@en

prefLabel

Clearance of Alzheimer's amylo ...... n-1 at the blood-brain barrier

@ast

Clearance of Alzheimer's amylo ...... n-1 at the blood-brain barrier

@en

P1433

Q33928434-6B987F5B-6B38-47A4-9C16-5FC0B7DD3433

P1476

Q33928434-97F984AE-8F1D-4ECE-B4E9-A980D11D0E2B

P2093

Q33928434-0874C451-7F37-40F2-9403-CFB821A03CB3

Q33928434-2042E39A-2EE1-480F-B73A-3053E798D794

Q33928434-3ACAFCCE-1402-4EA4-B193-DCCED1A187BC

Q33928434-43A6BBB5-F0B8-4C9A-8C24-894AB2BE87FB

Q33928434-444B5C9A-C2B5-4C40-81EB-A17BB8D0FD37

Q33928434-8550B18B-778A-4D9D-AC4E-9FEF9CA92C4E

Q33928434-BAB80CB1-F4D2-4AFF-A4F5-C83231217CDA

Q33928434-D30C295F-605C-415F-89F0-61D6DE617B92

Q33928434-D8D7DC26-D4E1-4392-9078-3D364F0AB6B2

Q33928434-F237B6D4-0321-4F9E-B44F-A58E6AFFAD1E

P2860

Q33928434-03242111-3DA0-490C-B628-0EB5E1E5424A

Q33928434-05852CC0-2237-4D46-95DD-DD9413467FE1

Q33928434-0E0F4645-9617-4799-91A0-9FF6F3D3A45E

Q33928434-10367684-D062-42D3-A93D-A3BB0F3F57F3

Q33928434-12EE5826-0BB1-497A-92DB-7E499DBC02AF

Q33928434-1B331942-87CC-4068-ACF0-3233BABAC16A

Q33928434-1D3305CE-DE3E-40DD-AA24-F88C8ED6A91C

Q33928434-24A38C3F-0A78-4A21-9E16-545F5A31F9EE

Q33928434-2F10ABBA-0468-464B-8768-CCC48F5114C7

Q33928434-3061BF79-C960-49BD-A29E-2F57898C501C

P304

Q33928434-90A5DF11-B9C6-44FF-A547-B78677C4BBE8

P31

Q33928434-521559E4-CBEF-4A58-8ECA-1E360D5C7798

P356

Q33928434-1D7DE25F-FBD8-4DA3-B9A2-F4527B5810DE

P407

Q33928434-1962F716-19AC-4BDB-ACFE-457370E094A1

P433

Q33928434-1A7FF6DF-F940-41B0-97B6-896CF1C258A0

P478

Q33928434-F0CB0C7F-2B41-41F7-A7C6-9987E89CDD74

P50

Q33928434-BDE8A468-DB72-4123-9170-915F0AAA8C98

P577

Q33928434-C244BBA9-65B6-404A-A551-E11066AB1436

P698

Q33928434-6BE9A3F1-37B4-47A8-9E3F-AC49C19739D7

P921

Q33928434-81B7D7E8-94CA-4BFB-B091-7F5BD3FF35F6

Q33928434-ADAB5A2A-1A0B-4AB7-A1D3-F9B13518309B

P932

Q33928434-C1207C3D-AFF0-4F68-B732-934842EA6D5B

P356

P1433

Journal of Clinical Investigation

P1476

Clearance of Alzheimer's amylo ...... n-1 at the blood-brain barrier

@en

P2093

B Frangione

http://www.w3.org/2001/XMLSchema#string

B V Zlokovic

http://www.w3.org/2001/XMLSchema#string

C A Miller

http://www.w3.org/2001/XMLSchema#string

D K Strickland

http://www.w3.org/2001/XMLSchema#string

D M Holtzman

http://www.w3.org/2001/XMLSchema#string

J Bading

http://www.w3.org/2001/XMLSchema#string

J Ghiso

http://www.w3.org/2001/XMLSchema#string

M Shibata

http://www.w3.org/2001/XMLSchema#string

S R Kumar

http://www.w3.org/2001/XMLSchema#string

S Yamada

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition

Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor

Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease.

Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau.

P304

1489-1499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI10498

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11120756

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

blood–brain barrier

P932

387254

http://www.w3.org/2001/XMLSchema#string